Insider Transactions in Q3 2020 at Adaptive Biotechnologies Corp (ADPT)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2020
|
Susan Bobulsky Chief Commercial Officer, MRD |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$500,000
$50.0 P/Share
|
|
Sep 29
2020
|
Susan Bobulsky Chief Commercial Officer, MRD |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$10,000
$1.98 P/Share
|
|
Sep 29
2020
|
Lance Baldo Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$1,250,000
$50.0 P/Share
|
|
Sep 29
2020
|
Lance Baldo Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$175,000
$7.8 P/Share
|
|
Sep 29
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
1,900
-0.11%
|
$95,000
$50.18 P/Share
|
|
Sep 29
2020
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+0.11%
|
$0
$0.33 P/Share
|
|
Sep 29
2020
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
80,000
-100.0%
|
$3,920,000
$49.0 P/Share
|
|
Sep 29
2020
|
Julie Rubinstein President |
BUY
Exercise of conversion of derivative security
|
Direct |
80,000
+50.0%
|
$0
$0.84 P/Share
|
|
Jul 20
2020
|
David E. Goel Director |
SELL
Open market or private sale
|
Indirect |
2,000,000
-13.23%
|
$80,000,000
$40.0 P/Share
|